BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Joanne E. F. Costa, Viviane M. S. Morais, Juliana P. Gonçales, Ana Anizia D. P. Medeiros, Haline Barroso, Adriana P. Compri, Lucila Fukasawa, Regina C. Moreira, Maria Rosângela C. D. Coêlho. Occult hepatitis B virus infection in patients with leprosyJournal of Medical Virology 2019; 91(5): 775 doi: 10.1002/jmv.25374
2
Davod Javanmard, Mohammad Hasan Namaei, Mohammad Farahmand, Arash Ziaee, Elham Amini, Masood Ziaee. Molecular and serological characterization of occult hepatitis B virus infection among patients with hemophiliaJournal of Medical Virology 2019; 91(8): 1519 doi: 10.1002/jmv.25470
3
Fujiko Mitsumoto-Kaseida, Masayuki Murata, Koji Takayama, Kazuhiro Toyoda, Eiichi Ogawa, Norihiro Furusyo, Jun Hayashi. Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patientsJournal of Infection and Chemotherapy 2020; 26(1): 28 doi: 10.1016/j.jiac.2019.06.003
4
R. A. A. Pondé. Molecular mechanisms underlying HBsAg negativity in occult HBV infectionEuropean Journal of Clinical Microbiology & Infectious Diseases 2015; 34(9): 1709 doi: 10.1007/s10096-015-2422-x
5
Ricardo Wagner de Almeida, Francisco Campello do Amaral Mello, Isabelle Vasconcelos Menegoy, Márcia Paschoal do Espírito Santo, Cléber Ferreira Ginuíno, Paulo Sérgio Fonseca de Sousa, Livia Melo Villar, Elisabeth Lampe, Lia Laura Lewis-Ximenez. Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in BrazilMemórias do Instituto Oswaldo Cruz 2017; 112(7): 485 doi: 10.1590/0074-02760160477
6
Chul S. Hyun, Seulgi Lee, William R. Ventura. The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic populationBMC Research Notes 2019; 12(1) doi: 10.1186/s13104-019-4287-z
7
C. R. Seed, P. Kiely, V. C. Hoad, A. J. Keller. Refining the risk estimate for transfusion-transmission of occult hepatitis B virusVox Sanguinis 2017; 112(1): 3 doi: 10.1111/vox.12446
8
Claudia Bozza, Marika Cinausero, Donatella Iacono, Fabio Puglisi. Hepatitis B and cancer: A practical guide for the oncologistCritical Reviews in Oncology/Hematology 2016; 98: 137 doi: 10.1016/j.critrevonc.2015.10.017
9
David J. Weber, William A. Rutala. Plotkin's Vaccines2018; : 1402 doi: 10.1016/B978-0-323-35761-6.00072-9
10
Hong Yongzhi, Xu Min, Yu Bo, Chen Pin, Shi Xueqiang. The correlation between renal transplantation and liver carcinoma: a meta-analysisOncotarget 2017; 8(40): 68928 doi: 10.18632/oncotarget.19456
11
Alberto Enrico Maraolo, Ivan Gentile, Antonio Riccardo Buonomo, Biagio Pinchera, Guglielmo Borgia. Current evidence on the management of hepatitis B in pregnancyWorld Journal of Hepatology 2018; 10(9): 585-594 doi: 10.4254/wjh.v10.i9.585
12
Neziha Yılmaz, Aydın Çifci, Mehmet Balcı, Salih Cesur, Seda Sabah Özcan, S. Süha Şen, Reyhan Öztürk, Çiğdem Kader, Hasan Irmak, Mehmet İbiş, Laser Sanal. Hemodiyaliz hastalarında okült hepatit B ve hepatit C enfeksiyonu sıklığıOrtadoğu Tıp Dergisi 2018;  doi: 10.21601/ortadogutipdergisi.324840
13
Agoritsa Varaklioti, Anna Kouramba, Panagiota Ioannidou, Olga Katsarou. Occult hepatitis B virus infection in Greek patients with congenital bleeding disordersInfection, Genetics and Evolution 2017; 54: 397 doi: 10.1016/j.meegid.2017.07.012
14
María L. Hepatitis B Virus (HBV) and S-Escape Mutants: From the Beginning until NowJournal of Human Virology & Retrovirology 2015; 2(3) doi: 10.15406/jhvrv.2015.02.00046
15
Li-Ping Hu, De-Ping Liu, Qin-Yan Chen, Tim J. Harrison, Xiang He, Xue-Yan Wang, Hai Li, Chao Tan, Qing-Li Yang, Kai-Wen Li, Zhong-Liao Fang, Tatsuo Kanda. Occult HBV Infection May Be Transmitted through Close Contact and Manifest as an Overt InfectionPLOS ONE 2015; 10(10): e0138552 doi: 10.1371/journal.pone.0138552
16
Pranatharthi H. Chandrasekar, Miriam T. Levine. Occult Hepatitis B Virus Reactivation in a Seronegative Stem Cell Transplant RecipientInfectious Diseases in Clinical Practice 2017; 25(2): 97 doi: 10.1097/IPC.0000000000000472
17
Liu Yang, Tingting Li, Wenmin Li, Xi Tang, Jinfeng Li, Ruiwen Long, Yongshui Fu, Jean-Pierre Allain, Chengyao Li. Occult Hepatitis B Virus Infection in Hyperlipidemia PatientsThe Tohoku Journal of Experimental Medicine 2017; 241(4): 255 doi: 10.1620/tjem.241.255
18
Fatma Amer, Monkez M. Yousif, Heba Mohtady, Rania A. Khattab, Ergenekon Karagoz, Khan F.M. Ayaz, Noha M. Hammad. Surveillance and impact of occult hepatitis B virus, SEN virus, and torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infectionInternational Journal of Infectious Diseases 2020; 92: 13 doi: 10.1016/j.ijid.2019.12.011
19
Resat Ozaras, Bilgul Mete, Fehmi Tabak. Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting AntiviralsClinical Gastroenterology and Hepatology 2017; 15(4): 605 doi: 10.1016/j.cgh.2016.11.030
20
Ji Yun Lee, Sung Hee Lim, Min-Young Lee, Haesu Kim, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Chul Won Jung, Jun Ho Jang, Won Seog Kim, Seok Jin Kim, Kihyun Kim. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapyLiver International 2015; 35(11): 2363 doi: 10.1111/liv.12838
21
Shan-Shan Wu, Quan-Yuan Shan, Wen-Xuan Xie, Bin Chen, Yang Huang, Yu Guo, Xiao-Yan Xie, Ming-De Lu, Bao-Gang Peng, Ming Kuang, Shun-Li Shen, Wei Wang. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinomaClinical and Translational Oncology 2020; 22(3): 401 doi: 10.1007/s12094-019-02141-8
22
R. Huang, X. Yan, J. Xia, J. Wang, C. Wu. Letter: hepatitis B virus reactivation in patients with chronic hepatitis C during direct-acting anti-viral therapyAlimentary Pharmacology & Therapeutics 2017; 45(12): 1558 doi: 10.1111/apt.14080
23
Tatiane Cinquini Moraes, Fabíola Souza Fiaccadori, Menira Souza, Tâmera Nunes Vieira Almeida, Marielton dos Passos Cunha, Ítalo de Araújo Castro, Divina das Dôres de Paula Cardoso. Hepatitis B virus infection among institutionalized mentally ill patients in BrazilThe Brazilian Journal of Infectious Diseases 2015; 19(6): 643 doi: 10.1016/j.bjid.2015.07.007
24
Shweta Bhatt. Induced Pluripotent Stem-cell Lines in the Clinic - Still a Long Road AheadJournal of Human Virology & Retrovirology 2015; 2(3) doi: 10.15406/jhvrv.2015.02.00044
25
Hao Liao, Yan Liu, Jianhong Chen, Weiping Ding, Xiaodong Li, Zhihui Xu, Yuan Yang, Rongjuan Chen, Lanlan Si, Xiaoyuan Xu, Jianxun Guo, Dongping Xu. Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North ChinaTransfusion 2017; 57(3pt2): 857 doi: 10.1111/trf.14046
26
Hao Wang, Min Wang, Jieting Huang, Ru Xu, Qiao Liao, Zhengang Shan, Yourong Zheng, Xia Rong, Xi Tang, Tingting Li, Wenjing Wang, Chengyao Li, Yongshui Fu. Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detectionJournal of Viral Hepatitis 2020;  doi: 10.1111/jvh.13309
27
Awa Abdul Carimo, Eduardo Samo Gudo, Cremildo Maueia, Nédio Mabunda, Lúcia Chambal, Adolfo Vubil, Ana Flora, Francisco Antunes, Nilesh Bhatt, Pierre Roques. First report of occult hepatitis B infection among ART naïve HIV seropositive individuals in Maputo, MozambiquePLOS ONE 2018; 13(1): e0190775 doi: 10.1371/journal.pone.0190775
28
C. Trigo, P. E. A. A. do Brasil, M. J. M. Costa, L. de Castro. Occult hepatitis B virus infection: clinical implications in tuberculosis treatmentJournal of Viral Hepatitis 2016; 23(12): 1027 doi: 10.1111/jvh.12583
29
X. Wen, H. Su, Y. Wang, Z. Pu, J. Gao, Z. Ji, X. Yuan, X. Li, W. Zhang, L. Zhang, Y. Long, Y. Yan, Z. Shao. Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, ChinaJournal of Viral Hepatitis 2018; 25(3): 281 doi: 10.1111/jvh.12805
30
M. Sh. Khubutiya, S. A. Solonin, M. A. Godkov. THE PROBLEMS OF PROVIDING INFECTIOUS DISEASE SAFETY FOR ORGAN AND TISSUE DONATION BY SCREENING BLOOD-BORNE VIRAL INFECTIONSRussian Journal of Transplantology and Artificial Organs 2016; 18(1): 83 doi: 10.15825/1995-1191-2016-1-83-90
31
Tayibe Bal, Yusuf Onlen. The prevalence of occult hepatitis B in chronic hepatitis C patients treated with interferon-based antiviral therapyArab Journal of Gastroenterology 2018; 19(1): 33 doi: 10.1016/j.ajg.2018.02.001
32
Ashish Goyal, Ranjit Chauhan. The dynamics of integration, viral suppression and cell-cell transmission in the development of occult Hepatitis B virus infectionJournal of Theoretical Biology 2018; 455: 269 doi: 10.1016/j.jtbi.2018.06.020
33
Ryu Watanabe, Tomonori Ishii, Hideo Harigae. Pretreatment Screening for Hepatitis B Virus Infection in Patients with Systemic Lupus ErythematosusThe Tohoku Journal of Experimental Medicine 2015; 237(1): 9 doi: 10.1620/tjem.237.9
34
Zohreh Azarkar, Masood Ziaee, Azadeh Ebrahimzadeh, Gholamreza Sharifzadeh, Davod Javanmard. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjectsJournal of Medical Virology 2019; 91(4): 615 doi: 10.1002/jmv.25343
35
A. Akram, S. M. R. Islam, S. U. Munshi, S. Tabassum. Detection of Hepatitis B Virus DNA among Chronic and potential Occult HBV patients in resource-limited settings by Loop-Mediated Isothermal Amplification assayJournal of Viral Hepatitis 2018; 25(11): 1306 doi: 10.1111/jvh.12931
36
Marina P. Oliveira, Márcia A. D. Matos, Ágabo M. C. Silva, Carmen L. R. Lopes, Sheila A. Teles, Marcos A. Matos, Natália Spitz, Natalia M. Araujo, Rosa M. S. Mota, Ligia R. F. S. Kerr, Regina M. B. Martins, Zhefeng Meng. Prevalence, Risk Behaviors, and Virological Characteristics of Hepatitis B Virus Infection in a Group of Men Who Have Sex with Men in Brazil: Results from a Respondent-Driven Sampling SurveyPLOS ONE 2016; 11(8): e0160916 doi: 10.1371/journal.pone.0160916
37
Molecular Microbiology2016; : 449 doi: 10.1128/9781555819071.ch32
38
Junichi Muraishi, Michihiko Shibata, Yuichi Honma, Masaaki Hiura, Shintaro Abe, Masaru Harada. Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant LymphomaInternal Medicine 2017; 56(15): 1967 doi: 10.2169/internalmedicine.56.8233
39
Safae Elkochri, Mohamed Rida Tagajdid, Rachid Abi, Hicham Elannaz, Idriss Lahlou Amine. Hépatite B occulte : un diagnostic à ne pas méconnaîtreRevue Francophone des Laboratoires 2018; 2018(502): 67 doi: 10.1016/S1773-035X(18)30151-5
40
Xichao Mo, Xuwen Xu, Zuning Ren, Junjie Guan, Jie Peng. Patients with tuberculous meningitis and hepatitis B co-infection have increased risk for antituberculosis drug-induced liver injury and poor outcomesInfectious Diseases 2020; : 1 doi: 10.1080/23744235.2020.1788223
41
Hidetaka Matsuda, Katsushi Hiramatsu, Yu Akazawa, Takuto Nosaka, Yasushi Saito, Yoshihiko Ozaki, Ryoko Hayama, Kazuto Takahashi, Tatsushi Naito, Kazuya Ofuji, Masahiro Ohtani, Tomoyuki Nemoto, Yukio Hida, Hideki Kimura, Yoshihiro Soya, Yasunari Nakamoto. Genetic polymorphism and decreased expression of HLA class II DP genes are associated with HBV reactivation in patients treated with immunomodulatory agentsJournal of Medical Virology 2018; 90(4): 712 doi: 10.1002/jmv.25011
42
Marc G. Ghany, Naveen Gara. Schiff's Diseases of the Liver2017; : 584 doi: 10.1002/9781119251316.ch24